410 Medical, Inc., a Durham, N.C.-based medical device company focused on developing innovative technologies for the resuscitation of critically ill patients, received $2.1m in additional funding for its Series A financing, bringing the Series A total to $5.3m.
Backers included Triangle Venture Alliance (TVA), a newly formed alliance among angel networks at Duke University, North Carolina State University, North Carolina Central University and the University of North Carolina at Chapel Hill.
The company intends to use the funds to further support the commercialization of the LifeFlow Rapid Infuser.
Founded in 2013 and led by Kyle Chenet, President and Chief Executive Officer, 410 Medical is commercializing LifeFlow, a device that allows for the rapid delivery of fluids in patients with sepsis, shock or other emergency conditions. The company is currently expanding LifeFlow’s release to hospitals and emergency medical services (EMS) organizations nationwide.
LifeFlow was cleared by the FDA for human use in 2016.